Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$80.52 - $93.75 $203,393 - $236,812
2,526 New
2,526 $214,000
Q1 2022

May 13, 2022

SELL
$80.11 - $90.62 $202,197 - $228,724
-2,524 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$81.78 - $95.14 $8,178 - $9,514
-100 Reduced 3.81%
2,524 $206,000
Q2 2021

Aug 13, 2021

SELL
$85.24 - $94.15 $55,746 - $61,574
-654 Reduced 19.95%
2,624 $239,000
Q1 2021

May 14, 2021

BUY
$83.5 - $98.47 $63,710 - $75,132
763 Added 30.34%
3,278 $280,000
Q4 2020

Feb 12, 2021

BUY
$78.07 - $94.43 $12,959 - $15,675
166 Added 7.07%
2,515 $237,000
Q3 2020

Nov 13, 2020

SELL
$82.14 - $91.0 $9,363 - $10,374
-114 Reduced 4.63%
2,349 $204,000
Q2 2020

Aug 13, 2020

BUY
$80.93 - $91.1 $199,330 - $224,379
2,463 New
2,463 $215,000
Q1 2020

May 11, 2020

SELL
$70.67 - $99.01 $159,784 - $223,861
-2,261 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$84.35 - $95.37 $190,715 - $215,631
2,261 New
2,261 $214,000
Q3 2019

Nov 13, 2019

SELL
$85.54 - $94.26 $193,405 - $213,121
-2,261 Closed
0 $0
Q2 2019

Aug 02, 2019

SELL
$75.4 - $92.8 $38,378 - $47,235
-509 Reduced 18.38%
2,261 $206,000
Q4 2018

Feb 08, 2019

SELL
$73.66 - $82.02 $54,803 - $61,022
-744 Reduced 21.17%
2,770 $238,000
Q3 2018

Nov 13, 2018

BUY
$66.94 - $77.43 $27,847 - $32,210
416 Added 13.43%
3,514 $303,000
Q2 2018

Dec 21, 2018

BUY
$64.91 - $73.36 $201,091 - $227,269
3,098 New
3,098 $234,000
Q2 2018

Aug 09, 2018

SELL
$64.91 - $73.36 $243,152 - $274,806
-3,746 Closed
0 $0
Q1 2018

Dec 21, 2018

BUY
$70.39 - $84.15 $263,680 - $315,225
3,746 New
3,746 $303,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $216B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cpwm, LLC Portfolio

Follow Cpwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cpwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cpwm, LLC with notifications on news.